| Date | Price Target | Rating | Analyst |
|---|
Fastest customizable press release news feed in the world
SOUTH SAN FRANCISCO, Calif. and ANN ARBOR, Mich., June 22, 2021 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. ("Tempest"), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, and Millendo Therapeutics, Inc. (NASDAQ:MLND) ("Millendo"), announced today the results for the proposals voted upon by Millendo stockholders at a Special Meeting on June 22, 2021. The stockholders voted in favor of all proposals at the Special Meeting, including to approve the proposed merger between the companies. The closing of the merger is anticipated to take place on or around Friday, June 25, 2021. Following the closin
SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Tempest Therapeutics, Inc. (“Tempest”), a privately-held clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, and Millendo Therapeutics, Inc. (Nasdaq: MLND) (“Millendo”), announced today that they have entered into a definitive agreement under which Millendo will merge with Tempest in an all-stock transaction. The combined company will focus on advancing Tempest’s oncology pipeline of small molecule therapeutics that have the potential to address a wide range of tumors. Upon shareholder approval, the combined company is expected to
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
3 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
3 - Tempest Therapeutics, Inc. (0001544227) (Issuer)
4 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
3 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
4 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
4 - Millendo Therapeutics, Inc. (0001544227) (Issuer)
8-K - Tempest Therapeutics, Inc. (0001544227) (Filer)
8-K/A - Millendo Therapeutics, Inc. (0001544227) (Filer)
8-K - Millendo Therapeutics, Inc. (0001544227) (Filer)
8-K - Millendo Therapeutics, Inc. (0001544227) (Filer)
8-K - Millendo Therapeutics, Inc. (0001544227) (Filer)
425 - Millendo Therapeutics, Inc. (0001544227) (Subject)
10-Q - Millendo Therapeutics, Inc. (0001544227) (Filer)
EFFECT - Millendo Therapeutics, Inc. (0001544227) (Filer)
424B3 - Millendo Therapeutics, Inc. (0001544227) (Filer)
S-4/A - Millendo Therapeutics, Inc. (0001544227) (Filer)
This live feed shows all institutional transactions in real time.
SC 13G - Tempest Therapeutics, Inc. (0001544227) (Subject)
SC 13G - Tempest Therapeutics, Inc. (0001544227) (Subject)
SC 13D/A - Millendo Therapeutics, Inc. (0001544227) (Subject)
SC 13G - Millendo Therapeutics, Inc. (0001544227) (Subject)
SC 13G/A - Millendo Therapeutics, Inc. (0001544227) (Subject)
SC 13G/A - Millendo Therapeutics, Inc. (0001544227) (Subject)